Readable, clinically-focused, actionable answers to inform point-of-care decision-making for health professionals.
Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically-focused entry point to rigorous research from Cochrane Reviews. They are designed to be actionable and to inform point-of-care decision-making. Each CCA contains a clinical question, a short answer, and data for the outcomes from the Cochrane Review deemed most relevant to practicing healthcare professionals. The evidence is displayed in a user-friendly tabulated format that includes narratives, data, and links to graphics.
COVID-19 CCAs are available for free. Latest COVID CCAs:
- Can pre‐exposure SARS‐CoV‐2‐neutralising monoclonal antibodies help prevent COVID‐19?
- Can postexposure SARS‐CoV‐2‐neutralising monoclonal antibodies help prevent COVID‐19?
- What are the effects of janus kinase (JAK) inhibitors for people with moderate to severe COVID‐19?
- What is the accuracy of World Health Organization (WHO)‐specified and related COVID‐19 symptoms for the diagnosis of COVID‐19?
- What evidence is available on unintended health and societal consequences of measures implemented in the school setting to contain the COVID‐19 pandemic?
Get involved: The clinical answer is written either by a practicing clinician or by a CCA Editor, with the answer being peer-reviewed by a practicing clinician. If you would like to join the Clinical Answers authoring team, please contact the team at email@example.com. We are specifically looking for clinicians in the following areas: respiratory medicine; care of the elderly; cardiovascular medicine; pregnancy and childbirth; neurology - especially epilepsy; infectious disease; paediatrics; rheumatology; ENT; and urology.